要查看或添加评论,请登录
Nimbus Search Partners的更多文章
-
2024年3月26日
Transforming Healthcare with Generative AI
Nimbus Search Partners : NVIDIA today launched more than two dozen new microservices that allow healthcare enterprises…
2
-
2024年3月25日
Penn Engineers Target Lung Disease with Lipid Nanoparticles
Nimbus Search Partners : Penn Engineers have developed a new means of targeting the lungs with lipid nanoparticles…
1
-
2024年3月14日
Regulatory Affairs: Advancing Your Career Amidst Change".
Nimbus Search Partners : In light of recent industry layoffs, I've compiled a list of open roles in Regulatory Affairs…
2
-
2024年3月12日
The Rise of Generative AI Across the C-Suite
Nimbus Search Partners : Generative AI continues to emerge as the shiny new thing this year, with new iterations coming…
2
1 条评论 -
2024年3月6日
FDA approves first interchangeable biosimilars to Prolia and Xgeva to treat certain types of osteoporosis and prevent bone events in cancer
Nimbus Search Partners : This week FDA approved Jubbonti (denosumab-bbdz) injection as an interchangeable biosimilar to…
2
-
2024年3月6日
FDA Clears First Over-the-Counter Continuous Glucose Monitor
Nimbus Search Partners : On March 5, 2024, the U.S.
1
-
2023年9月28日
The Impact of AI on Advanced Analytics, Bioinformatics, and Public Health Agencies.
Nimbus Search Partners : Artificial Intelligence (AI) has emerged as a revolutionary force, reshaping industries and…
2
-
2023年9月21日
Leveraging AI for Public Health Agencies: Enhancing Efficiency and Outcomes.
Nimbus Search Partners : In the modern era, the rapid advancement of technology has opened up new avenues for…
2
-
2023年9月18日
Leveraging the Transformational Potential of AI in Rare Disease Drug Development.
Nimbus Search Partners : Artificial Intelligence (AI) has revolutionized various sectors, and the field of healthcare…
3
-
2023年9月11日
The Evolution of Wearables and the Impact of AI on Personalized Digital Health Solutions.
Nimbus Search Partners : In the rapidly evolving landscape of technology and healthcare, wearables have emerged as a…
3
社区洞察
-
Market AccessHow do you design a value-based contract for a new gene therapy?
-
BiotechnologyWhat are the best practices for designing experiments with genetic engineering?
-
Patient AdvocacyHow can you support patients in genetic testing decisions?
-
BiotechnologyWhat are the key steps to troubleshooting analytical techniques for gene therapy?
-
BiotechnologyYou're looking for a reliable gene expression analysis service. What's the best way to find one?
-
HealthcareWhat do you do if your treatment plan needs personalization using genetic testing?
-
BiotechnologyYou're faced with conflicting genetic testing results. How do you navigate this medical mystery?
其他会员也浏览了
-
Gene Therapy’s Financial Blueprint: Cost vs. Cure
RemedyOne 1 年 -
HTA and cell and gene therapy
Jason Shafrin 8 个月 -
Reaching Beyond the Limits of Enzyme Replacement Therapies with Gene Therapies
Daniel Levine 2 年 -
Rethinking How Cell and Gene Therapies Are Made to Improve Accessibility
Daniel Levine 2 年 -
Stoking Functional Copies of Genes to Compensate for Mutated Ones
Daniel Levine 2 年 -
Developing in Vivo Gene Editors that Target Liver Diseases
Daniel Levine 3 年 -
Addressing the Delivery Challenges of Genetic Medicines
Daniel Levine 3 年 -
A Bet on a Unique Set of Vectors
Daniel Levine 3 年 -
Tackling the Pricing Challenges for Advanced Therapies for Rare Diseases
Daniel Levine 2 年 -
Part 2-Gene Therapy: A Patient Advocate's Perspective
Daniel Levine 4 年